Erin Colgan

Insider Reports History

Location
Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin Colgan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 67,462 $53,295 $0.7900 15 Feb 2024 Direct
Sensei Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 94,128 15 Feb 2024 Direct

Insider Reports Filed by Erin Colgan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2024 3 -$2,865 4 CHIEF FINANCIAL OFFICER 16 Feb 2024, 18:25
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2023 1 -$16,414 4 Chief Financial Officer 11 Sep 2023, 17:31
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2023 3 $0 4/A Chief Financial Officer 29 Mar 2023, 17:17
SNSE Sensei Biotherapeutics, Inc. 15 Feb 2022 2 $0 4 Chief Financial Officer 17 Feb 2022, 17:21